Status:
COMPLETED
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
Lead Sponsor:
AstraZeneca
Conditions:
Bronchial Asthma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to confirm the safety (ADR related to beta stimulant drugs, unexpected ADRs) and efficacy of Symbicort in daily practice and the control status on bronchial asthma and Pat...
Eligibility Criteria
Inclusion
- Patients treated with Symbicort for the first time due to bronchial asthma
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
3643 Patients enrolled
Trial Details
Trial ID
NCT01232348
Start Date
January 1 2010
End Date
October 1 2011
Last Update
December 7 2011
Active Locations (47)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Okazaki, Aichi-ken, Japan
2
Research Site
Akita, Akita, Japan
3
Research Site
Aomori, Aomori, Japan
4
Research Site
Chiba, Chiba, Japan